54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jun 30
13:55 UTC
|
BX
Blackstone
|
◎ Target | firm only | Neutral | $126.00→ $125.00-0.8% |
|
Jun 30
13:55 UTC
|
ALB
Albemarle
|
◎ Target | firm only | Buy | $244.00→ $211.00-13.5% |
|
Jun 30
13:55 UTC
|
ABVX
Abivax
|
◎ Target | David Nierengarten ★★☆☆☆ #2336 | Neutral | $90.00→ $110.00+22.2% |
|
Jun 30
13:55 UTC
|
TFC
Truist Financial
|
↓ Downgrade | firm only | Buy→ Neutral | $54.00 |
|
Jun 30
13:55 UTC
|
TECH
Bio-Techne
|
↓ Downgrade | Robert Wasserman ★★★☆☆ #1922 | Buy→ Hold | |
|
Jun 30
13:55 UTC
|
STNG
Scorpio Tankers
|
↓ Downgrade | Ken Hoexter ★★★☆☆ #1449 | Buy→ Underperform | $78.00 |
|
Jun 30
13:55 UTC
|
OLN
Olin
|
↓ Downgrade | firm only | Buy→ Underperform | $21.00 |
|
Jun 30
13:55 UTC
|
MS
Morgan Stanley
|
↓ Downgrade | Chris Kotowski ★★★★☆ #657 | Market Perform→ Underperform | |
|
Jun 30
13:55 UTC
|
LOGI
Logitech International
|
↓ Downgrade | firm only | Neutral→ Underperform | $86.00 |
|
Jun 30
13:55 UTC
|
GS
The Goldman Sachs Group
|
↓ Downgrade | Chris Kotowski ★★★★☆ #657 | Market Perform→ Underperform | |
|
Jun 30
13:55 UTC
|
FOXF
Fox Factory
|
↓ Downgrade | firm only | Neutral→ Underperform | $20.00 |
|
Jun 30
13:55 UTC
|
BKU
BankUnited
|
↓ Downgrade | Benjamin Gerlinger not yet tracked | Neutral→ Sell | $45.00 |
|
Jun 30
13:55 UTC
|
BAK
Braskem
|
↓ Downgrade | Milene Carvalho not yet tracked | Overweight→ Neutral | |
|
Jun 30
13:55 UTC
|
ACAD
ACADIA Pharmaceuticals
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jun 30
13:55 UTC
|
WTS
Watts Water Technologies
|
↑ Upgrade | William Grippin ★★★☆☆ #1792 | Equal Weight→ Overweight | $317.00→ $414.00+30.6% |
|
Jun 30
13:55 UTC
|
TCBI
Texas Capital Bancshares
|
↑ Upgrade | Benjamin Gerlinger not yet tracked | Sell→ Neutral | $105.00 |
|
Jun 30
13:55 UTC
|
REPL
Replimune Group
|
↑ Upgrade | firm only | Underperform→ Outperform | $16.00 |
|
Jun 30
13:55 UTC
|
RBA
RB Global
|
↑ Upgrade | Steve Hansen ★★★☆☆ #1405 | Outperform→ Strong-Buy | $145.00 |
|
Jun 30
13:55 UTC
|
QLYS
Qualys
|
↑ Upgrade | Brian Essex ★★★☆☆ #1315 | Underweight→ Neutral | $139.00 |
|
Jun 30
13:55 UTC
|
PALAF
Paladin Energy
|
↑ Upgrade | firm only | Outperform | |
|
Jun 30
13:55 UTC
|
OC
Owens Corning
|
↑ Upgrade | firm only | In-Line→ Outperform | $188.00 |
|
Jun 30
13:55 UTC
|
NTR
Nutrien
|
↑ Upgrade | Ben Isaacson ★★★☆☆ #2034 | Sec→ r Perform ➝ Outperform | $80.00 |
|
Jun 30
13:55 UTC
|
HON
Honeywell International
|
↑ Upgrade | firm only | Neutral→ Outperform | $255.00 |
|
Jun 30
13:55 UTC
|
FBIN
Fortune Brands Innovations
|
↑ Upgrade | Keith Hughes ★★★☆☆ #1593 | Hold→ Buy | $70.00 |
|
Jun 30
13:55 UTC
|
CMCSA
Comcast
|
↑ Upgrade | Barton Crockett ★★★★☆ #685 | Neutral→ Buy | $24.00→ $31.00+29.2% |
|
Jun 30
13:55 UTC
|
CF
CF Industries
|
↑ Upgrade | Ben Isaacson ★★★☆☆ #2034 | Sec→ r Perform ➝ Sector Outperform | $125.00 |
|
Jun 30
12:55 UTC
|
VIRT
Virtu Financial
|
◎ Target | Alexander Blostein ★★★★☆ #451 | Neutral | $51.00→ $63.00+23.5% |
|
Jun 30
12:55 UTC
|
TSHA
Taysha Gene Therapies
|
◎ Target | Jack Allen ★★★☆☆ #2239 | Outperform | $12.00→ $15.00+25.0% |
|
Jun 30
12:55 UTC
|
MNPR
Monopar Therapeutics
|
◎ Target | Jeet Mukherjee ★★☆☆☆ #2323 | Buy | $104.00→ $117.00+12.5% |
|
Jun 30
12:55 UTC
|
MKTX
MarketAxess
|
◎ Target | Alexander Blostein ★★★★☆ #451 | Neutral | $168.00→ $130.00-22.6% |
|
Jun 30
12:55 UTC
|
LRMR
Larimar Therapeutics
|
◎ Target | Joel Beatty ★★☆☆☆ #2345 | Outperform | $7.00→ $5.00-28.6% |
|
Jun 30
12:55 UTC
|
ICE
Intercontinental Exchange
|
◎ Target | Alexander Blostein ★★★★☆ #451 | Buy | $208.00→ $180.00-13.5% |
|
Jun 30
12:55 UTC
|
HAPN
Lendingclub
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Buy | $20.00→ $25.00+25.0% |
|
Jun 30
12:55 UTC
|
EW
Edwards Lifesciences
|
◎ Target | Marie Thibault ★★★★☆ #791 | Buy | $100.00→ $110.00+10.0% |
|
Jun 30
12:55 UTC
|
ENVA
Enova International
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Buy | $199.00→ $270.00+35.7% |
|
Jun 30
12:55 UTC
|
COF
Capital One Financial
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Buy | $224.00→ $259.00+15.6% |
|
Jun 30
12:55 UTC
|
CNXC
Concentrix
|
◎ Target | David Koning ★★★★☆ #367 | Outperform | $40.00→ $30.00-25.0% |
|
Jun 30
12:55 UTC
|
BFH
Bread Financial
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Buy | $105.00→ $132.00+25.7% |
|
Jun 30
12:55 UTC
|
BCRX
BioCryst Pharmaceuticals
|
◎ Target | Steven Seedhouse ★☆☆☆☆ #2981 | Overweight | $27.00→ $29.00+7.4% |
|
Jun 30
12:55 UTC
|
AXP
American Express
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Sell | $285.00→ $324.00+13.7% |
|
Jun 30
12:55 UTC
|
ATLC
Atlanticus
|
◎ Target | Vincent Caintic ★★★☆☆ #1848 | Buy | $105.00→ $179.00+70.5% |
|
Jun 30
12:55 UTC
|
ATI
ATI
|
◎ Target | Michael Leshock ★★☆☆☆ #2855 | Overweight | $175.00→ $211.00+20.6% |
|
Jun 30
12:55 UTC
|
AR
Antero Resources
|
◎ Target | Neil Mehta ★★★☆☆ #1163 | Buy | $46.00→ $41.00-10.9% |
|
Jun 30
12:55 UTC
|
ABVX
Abivax
|
◎ Target | Julian Harrison ★☆☆☆☆ #2924 | Buy | $150.00→ $175.00+16.7% |
|
Jun 30
12:55 UTC
|
OLN
Olin
|
↓ Downgrade | Patrick Cunningham ★★★☆☆ #1493 | Neutral→ Underperform | |
|
Jun 30
12:55 UTC
|
MS
Morgan Stanley
|
↓ Downgrade | firm only | Market Perform→ Underperform | |
|
Jun 30
12:55 UTC
|
GS
The Goldman Sachs Group
|
↓ Downgrade | firm only | Outperform→ Underperform | |
|
Jun 30
12:55 UTC
|
GLOB
Globant
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Jun 30
12:55 UTC
|
EVMN
Evommune
|
↓ Downgrade | Mitchell S. not yet tracked | Buy→ Neutral | |
|
Jun 30
12:55 UTC
|
C
Citigroup
|
↓ Downgrade | Chris Kotowski ★★★★☆ #657 | Outperform→ Market Perform |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.